Evaluation the Feasibility of the FOSTI Device
NCT00791609 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2008-11-14
Summary
Feasibility of accurate differentiation between malignant and benign tissue using the FOSTI device on surgically removed tissue
Conditions
Sponsors & Collaborators
-
Optivasive Ltd.
lead INDUSTRY
Principal Investigators
-
Anatoliy Babchenko · Optivasive Ltd.
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-03-31
More Related Trials
-
The Application of Rapid Fresh Digital Pathology on the Diagnosis and Biomarker Testing of Lung Cancer
NCT06497686 ·Status: NOT_YET_RECRUITING
-
Phase 2 Study of VGT-309 in Lung Cancer
NCT05400226 ·Status: COMPLETED ·Phase: PHASE2
-
Association Between RVT and Prognosis After Neoadjuvant Targeted Therapy in EGFR NSCLC
NCT06771960 ·Status: RECRUITING
-
Development of Indices Predicting Response to Pre-operative Chemotherapy in Osteosarcoma Patients
NCT00686738 ·Status: COMPLETED
-
The Detection of Circulating Tumor Cells (CTCs) in Patients With Lung Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment
NCT02412384 ·Status: COMPLETED
-
The Role of Interventional Pulmonology, Microbiota and Immune Response in the Patient With Lung Cancer
NCT05164445 ·Status: COMPLETED ·Phase: NA
-
Tissue Collection Framework To Improve Outcomes In Solid Tumours
NCT03572192 ·Status: RECRUITING
-
A Prospective, Multi-Center Evaluation of a Powered Vascular Stapler in Video-Assisted Thoracoscopic Lobectomies
NCT03056300 ·Status: COMPLETED ·Phase: NA
-
HSI for Intersegmental Plane Identification During Sublobar Pulmonary Resections
NCT05676788 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluating the Predictive Capability of Transcriptomic Profiling for Identifying the Primary Site of Metastatic Tumors
NCT07319949 ·Status: NOT_YET_RECRUITING
-
The Feasibility of Dynamic Liquid Biopsy Monitoring During Neoadjuvant Treatment for EGFR-mutated NSCLC
NCT06287593 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01517971 ·Status: COMPLETED
-
Analysis of Risk Factors of Postoperative Pulmonary Infection in Patients With Esophageal Cancer
NCT05740852 ·Status: COMPLETED
-
Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early Stage Lung Cancer
NCT02933294 ·Status: UNKNOWN ·Phase: NA
-
Effect of CCRT on Respiratory Performance and Functional Capacity in Esophagus Cancer Patients
NCT01766349 ·Status: COMPLETED
-
Predictive Models of Treatment Responses and Survival Outcomes in Patients With Osteosarcoma
NCT05194605 ·Status: UNKNOWN
-
Randomized Study of Positron Emission Tomography - Computed Tomography (PET/CT) in Pre-Operative Staging of Lung Cancer
NCT00867412 ·Status: COMPLETED
-
Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer
NCT06930807 ·Status: RECRUITING ·Phase: NA
-
Low-dose Protocol for Computed Tomography-guided Lung Biopsy
NCT02971176 ·Status: COMPLETED ·Phase: NA
-
Prognostic Value of the 6-minute Stepper Test in Non-small Cell Lung Cancer Surgery
NCT03824977 ·Status: COMPLETED
-
Perioperative and Postoperative Circulating Tumor Cell Monitoring in Different Stage of NSCLC
NCT07186855 ·Status: COMPLETED
-
A Perioperative Comprehensive Diagnosis and Treatment System for Lung Cancer in the Era of Neoadjuvant Immunotherapy
NCT07119190 ·Status: NOT_YET_RECRUITING
-
68Ga-NK224 PET Imaging of PD-L1 Expression in Cancers
NCT06754345 ·Status: RECRUITING
-
The Relationship Between the Differential Expression of FosB Protein in Laryngeal Cancer Tissues and Clinical Prognosis
NCT06836765 ·Status: NOT_YET_RECRUITING
-
Full-Field Optical Coherence Tomography (FFOCT) for Evaluation of Bronchoscopic Small Biopsy Specimens
NCT05171478 ·Status: RECRUITING